Examination of Lower Limb Microcirculation in Diabetic Patients with and without Intermittent Claudication

Intermittent claudication is a frequent complaint in lower extremity artery disease, but approximately two thirds of patients are asymptomatic, most of which are diabetic patients. Non-invasive angiological and microrheological tests on diabetic subjects with and without intermittent claudication were performed in the present study. In total, 98 diabetic patients were included and divided into two groups: 20 patients (63.5 ± 8.8 years, 55% men, 45% women) had intermittent claudication, 78 patients (65.5 ± 9.3 years, 61.5% men, 38.5% women) were asymptomatic. Hand-held Doppler ultrasound examination, transcutaneous tissue partial oxygen pressure (tcpO2) measurement, Rydel–Seiffer tuning fork tests, and 6-min walk tests were performed, and erythrocyte aggregation was investigated. Ankle–brachial index (p < 0.02) and tcpO2, measured during provocation tests (p < 0.003) and the 6-min walk test (p < 0.0001), significantly deteriorated in the symptomatic group. A higher erythrocyte aggregation index and faster aggregate formation was observed in claudication patients (p < 0.02). Despite the statistically better results of the asymptomatic group, 13% of these patients had severe limb ischemia based on the results of tcpO2 measurement. Claudication can be associated with worse hemodynamic and hemorheological conditions in diabetic patients; however, severe ischemia can also develop in asymptomatic subjects. Non-invasive vascular tests can detect ischemia, which highlights the importance of early instrumental screening of the lower limbs.

[1]  R. Freeman,et al.  Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations. , 2021, Diabetes research and clinical practice.

[2]  G. Filippatos,et al.  2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. , 2020, European heart journal.

[3]  Y. Hung,et al.  Prevalence of diabetic macrovascular complications and related factors from 2005 to 2014 in Taiwan: A nationwide survey. , 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

[4]  N. Wong,et al.  Epidemiology of Diabetes Mellitus and Cardiovascular Disease , 2019, Current Cardiology Reports.

[5]  7. Diabetes Technology: Standards of Medical Care in Diabetes—2019 , 2018, Diabetes Care.

[6]  D. Bandyk The diabetic foot: Pathophysiology, evaluation, and treatment. , 2018, Seminars in vascular surgery.

[7]  10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2018 , 2017, Diabetes Care.

[8]  R. Freeman,et al.  Diabetic Neuropathy: A Position Statement by the American Diabetes Association , 2016, Diabetes Care.

[9]  M. Woodward,et al.  Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study , 2016, Cardiovascular Diabetology.

[10]  M. Woodward,et al.  Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes , 2016, Diabetes Care.

[11]  F. Moll,et al.  Critical Limb Ischemia: Current Trends and Future Directions , 2016, Journal of the American Heart Association.

[12]  T. Ferenci,et al.  Trends in Major Lower Limb Amputation Related to Peripheral Arterial Disease in Hungary: A Nationwide Study (2004-2012). , 2015, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[13]  V. Aboyans,et al.  Epidemiology of peripheral artery disease. , 2015, Circulation research.

[14]  N. Wareham,et al.  Epidemiology of diabetes , 2014, Medicine.

[15]  V. Aboyans,et al.  Risk Factors for Incident Peripheral Arterial Disease in Type 2 Diabetes: Results From the Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D) Trial , 2014, Diabetes Care.

[16]  P. Holt,et al.  The association of ulceration of the foot with cardiovascular and all-cause mortality in patients with diabetes: a meta-analysis , 2012, Diabetologia.

[17]  D. Clement,et al.  High prevalence of peripheral arterial disease in hypertensive patients: the Evaluation of Ankle-Brachial Index in Hungarian Hypertensives screening program , 2012, Journal of hypertension.

[18]  A. Ndip,et al.  Neuropathic diabetic foot ulcers – evidence-to-practice , 2012, International journal of general medicine.

[19]  Sherry L Pagoto,et al.  Sensitivity and specificity of the ankle—brachial index to diagnose peripheral artery disease: a structured review , 2010, Vascular medicine.

[20]  A Hofman,et al.  Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. , 2008, JAMA.

[21]  W. Hiatt,et al.  Peripheral arterial disease in patients with diabetes. , 2006, Journal of the American College of Cardiology.

[22]  P. Norman,et al.  Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study. , 2006, Diabetes Care.

[23]  Elizabeth Selvin,et al.  Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999–2000 , 2004, Circulation.

[24]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[25]  R. Holman,et al.  UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. , 2002, Diabetes care.

[26]  N. Powe,et al.  Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[27]  A. Lee,et al.  Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study , 1996, BMJ.

[28]  A. Veves,et al.  Rheological and microvascular parameters in diabetic peripheral neuropathy. , 1996, Clinical science.

[29]  W. Kannel Risk Factors for Atherosclerotic Cardiovascular Outcomes in Different Arterial Territories , 1994, Journal of cardiovascular risk.

[30]  R. Langer,et al.  Mortality over a period of 10 years in patients with peripheral arterial disease. , 1992, The New England journal of medicine.

[31]  I. Faris,et al.  Transcutaneous oxygen tension measurements in the assessment of limb ischaemia. , 1991, Clinical physiology.

[32]  M. Berger,et al.  Transcutaneous oxygen pressure measurements in type I diabetic patients for early detection of functional diabetic microangiopathy , 1988, European journal of clinical investigation.

[33]  E. Ernst,et al.  Intermittent claudication, exercise, and blood rheology. , 1987, Circulation.

[34]  J. Daube,et al.  Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. , 1985, Brain : a journal of neurology.

[35]  H. Blumenthal,et al.  Etiologic Considerations in Peripheral Vascular Diseases of the Lower Extremity with Special Reference to Diabetes Mellitus , 1966, Circulation.

[36]  D. Endrei,et al.  Lower limb ischemia and microrheological alterations in patients with diabetic retinopathy. , 2018, Clinical hemorheology and microcirculation.

[37]  Microvascular Complications and Foot Care : Standards of Medical Care in Diabetes d 2019 , 2018 .

[38]  V. Aboyans,et al.  Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases , in collaboration with the European Society for Vascular Surgery ( ESVS ) – Web Addenda , 2017 .

[39]  杨敏 ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease , 2014 .

[40]  David G Armstrong,et al.  The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). , 2014, Journal of vascular surgery.

[41]  O. Baskurt,et al.  Erythrocyte aggregation: basic aspects and clinical importance. , 2013, Clinical hemorheology and microcirculation.

[42]  John V. White,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[43]  Oguz K. Baskurt,et al.  Handbook of hemorheology and hemodynamics , 2007 .

[44]  L. Uccioli,et al.  High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study , 2006, Diabetologia.

[45]  M. Vimeux,et al.  Blood rheology in patients with diabetes mellitus. , 2004, Clinical hemorheology and microcirculation.

[46]  ATS Statement , 2002 .

[47]  ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.

[48]  N. Vaughan EASD European Association for the Study of Diabetes , 2002, Diabetologia.

[49]  J. Brun,et al.  [Rheology and occlusive arterial disease of the legs]. , 1996, Journal des maladies vasculaires.

[50]  J. Ward Diabetic neuropathy. , 1972, Clinics in Endocrinology and Metabolism.